BHC
insider transactionsBausch Health Companies Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-24.5K
0 buy · 24.5K sell
Net value · 90d
-$132.8K
$0 in · $132.8K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
1
0 buy · 24.5K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
45.9K sh
Own +17%
-
Grant·A
Director
$0
45.9K sh
Own New
-
Grant·A
Director
$0
45.9K sh
Own +18%
-
Grant·A
Director
$0
45.9K sh
Own +12%
-
Grant·A
Director
$0
45.9K sh
Own +103%
-
Grant·A
Director
$0
45.9K sh
Own +93%
-
Grant·A
Director
$0
45.9K sh
Own +19%
-
Grant·A
Director
$0
45.9K sh
Own +152%
-
Grant·A
Director
$0
45.9K sh
Own +51%
-
Sell·S
Director · 10b5-1
$132.8K
24.5K sh · $5.43
Own -33%
-
Grant·A
Director
$32.1K
5.9K sh · $5.40
Own +15%
-
Grant·A
Director
$62.5K
11.6K sh · $5.40
Own +3%
-
Grant·A
Director
$6.9K
1.3K sh · $5.40
Own +0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 22, 2026 | Amy B Wechsler | Grant A | 45.9K | $0 |
| May 22, 2026 | Eiry Roberts | Grant A | 45.9K | $0 |
| May 22, 2026 | Robert N Power | Grant A | 45.9K | $0 |
| May 22, 2026 | John Paulson | Grant A | 45.9K | $0 |
| May 22, 2026 | Sandra Leung | Grant A | 45.9K | $0 |
| May 22, 2026 | Frank D. Lee | Grant A | 45.9K | $0 |
| May 22, 2026 | Sarah B Kavanagh | Grant A | 45.9K | $0 |
| May 22, 2026 | Michael Goettler | Grant A | 45.9K | $0 |
| May 22, 2026 | Christian A Garcia | Grant A | 45.9K | $0 |
| May 19, 2026 | Frank D. Lee 10b5-1 | Sell S | 24.5K | $132.8K |
| Mar 31, 2026 | Sandra Leung | Grant A | 5.9K | $32.1K |
| Mar 31, 2026 | John Paulson | Grant A | 11.6K | $62.5K |
| Mar 31, 2026 | Amy B Wechsler | Grant A | 1.3K | $6.9K |
About BHC insider trading
This page tracks insider transactions for Bausch Health Companies Inc. (BHC) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.